• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.

作者信息

Tutuncu Z N, Bilgie A, Kennedy L G, Calin A

出版信息

Ann Rheum Dis. 1994 Jun;53(6):425-6. doi: 10.1136/ard.53.6.425-b.

DOI:10.1136/ard.53.6.425-b
PMID:7518664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1005361/
Abstract
摘要

相似文献

1
Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.强直性脊柱炎中的白细胞介素-6、急性期反应物与临床状况
Ann Rheum Dis. 1994 Jun;53(6):425-6. doi: 10.1136/ard.53.6.425-b.
2
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor.评价强直性脊柱炎的炎症和氧化应激：巨噬细胞移动抑制因子的作用。
Mod Rheumatol. 2010 Feb;20(1):34-9. doi: 10.1007/s10165-009-0230-9. Epub 2009 Sep 29.
3
Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis.鉴定可用于监测强直性脊柱炎英夫利昔单抗治疗的急性期反应物和细胞因子。
Clin Rheumatol. 2008 Nov;27(11):1429-35. doi: 10.1007/s10067-008-0941-x. Epub 2008 Jun 20.
4
Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.强直性脊柱炎中细胞因子信号转导抑制因子及其与疾病严重程度、急性期反应物和血清细胞因子的关联
Clin Exp Rheumatol. 2016 Jan-Feb;34(1):100-5. Epub 2016 Jan 20.
5
Acute-phase response, clinical measures and disease activity in ankylosing spondylitis.强直性脊柱炎的急性期反应、临床指标与疾病活动度
Joint Bone Spine. 2007 May;74(3):249-53. doi: 10.1016/j.jbspin.2006.07.005. Epub 2007 Mar 5.
6
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.与戈利木单抗治疗的强直性脊柱炎患者临床改善相关的血清标志物。
Ann Rheum Dis. 2012 May;71(5):674-80. doi: 10.1136/ard.2010.148890. Epub 2011 Oct 28.
7
The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis.吸烟对强直性脊柱炎患者临床及影像学变量和急性期反应物的影响。
Rheumatol Int. 2015 Dec;35(12):2109-14. doi: 10.1007/s00296-015-3381-3. Epub 2015 Oct 16.
8
Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study.强直性脊柱炎患者脂肪因子、白细胞介素-6和肿瘤坏死因子-α浓度与临床特征及脊柱骨桥存在情况的相关性：一项横断面研究
J Int Med Res. 2017 Jun;45(3):1024-1035. doi: 10.1177/0300060517708693. Epub 2017 May 23.
9
Biological and clinical markers of disease activity in ankylosing spondylitis.强直性脊柱炎疾病活动的生物学和临床标志物
J Rheumatol. 2003 Dec;30(12):2729-32.
10
Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis.中性粒细胞与淋巴细胞比值与强直性脊柱炎的治疗选择及炎症标志物相关
J Clin Lab Anal. 2015 Jul;29(4):294-8. doi: 10.1002/jcla.21768. Epub 2014 May 21.

引用本文的文献

1
Therapeutic potential of single-nucleotide polymorphism-mediated IL6R inhibitors in ankylosing spondylitis treatment.单核苷酸多态性介导的IL6R抑制剂在强直性脊柱炎治疗中的治疗潜力。
Front Med (Lausanne). 2024 May 21;11:1368346. doi: 10.3389/fmed.2024.1368346. eCollection 2024.
2
Gut Microbiota and Inflammatory Cytokine Changes in Patients with Ankylosing Spondylitis.肠内微生物群和炎症细胞因子变化在强直性脊柱炎患者中。
Biomed Res Int. 2022 Aug 19;2022:1005111. doi: 10.1155/2022/1005111. eCollection 2022.
3
Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression.治疗强直性脊柱炎的最佳生物制剂：一项网络荟萃分析和网络荟萃回归研究的结果。
Biomed Res Int. 2022 Jul 6;2022:8316106. doi: 10.1155/2022/8316106. eCollection 2022.
4
Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study.强直性脊柱炎患者脂肪因子、白细胞介素-6和肿瘤坏死因子-α浓度与临床特征及脊柱骨桥存在情况的相关性：一项横断面研究
J Int Med Res. 2017 Jun;45(3):1024-1035. doi: 10.1177/0300060517708693. Epub 2017 May 23.
5
The effect of IL-4 and MTHFR gene variants in ankylosing spondylitis.白细胞介素-4和亚甲基四氢叶酸还原酶基因变异在强直性脊柱炎中的作用。
Z Rheumatol. 2015 Feb;74(1):60-6. doi: 10.1007/s00393-014-1403-2.
6
Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis.强直性脊柱炎患者血清中细胞因子与SOCS-1甲基化之间的关联
Mol Biol Rep. 2014 Jun;41(6):3773-80. doi: 10.1007/s11033-014-3242-2. Epub 2014 Feb 16.
7
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials.评估托珠单抗治疗强直性脊柱炎的短期症状疗效：随机、安慰剂对照试验的结果。
Ann Rheum Dis. 2014 Jan;73(1):95-100. doi: 10.1136/annrheumdis-2013-203559. Epub 2013 Jun 13.
8
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.IL-6 是否为治疗抗 TNF 治疗抵抗的脊柱关节炎患者的合适靶点？一项多中心回顾性观察研究。
Arthritis Res Ther. 2012 Mar 9;14(2):R53. doi: 10.1186/ar3766.
9
The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.轻度全身热疗对强直性脊柱炎患者体内肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-6系统水平的影响。
Clin Rheumatol. 2009 Apr;28(4):397-402. doi: 10.1007/s10067-008-1059-x. Epub 2008 Dec 17.
10
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.英夫利昔单抗治疗后强直性脊柱炎患者的炎症生物标志物、疾病活动度及脊柱疾病指标
Ann Rheum Dis. 2008 Apr;67(4):511-7. doi: 10.1136/ard.2007.071605. Epub 2007 Jul 20.

本文引用的文献

1
The natural history of ankylosing spondylitis. Does it burn out?强直性脊柱炎的自然病史。它会自行缓解吗？
J Rheumatol. 1993 Apr;20(4):688-92.
2
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.类风湿关节炎及其他炎性关节炎患者滑液和血清中的白细胞介素-6
Arthritis Rheum. 1988 Jun;31(6):784-8. doi: 10.1002/art.1780310614.
3
Serum levels of interleukin-6 and acute phase responses.血清白细胞介素-6水平与急性期反应
Lancet. 1987 Oct 17;2(8564):921. doi: 10.1016/s0140-6736(87)91413-9.
4
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.脑膜炎球菌性感染性休克患者血清中细胞因子的复杂模式。白细胞介素6、白细胞介素1与致命结局之间的关联。
J Exp Med. 1989 Jan 1;169(1):333-8. doi: 10.1084/jem.169.1.333.
5
Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.手术引发炎症时，血清白细胞介素6在急性期蛋白之前升高。
Clin Immunol Immunopathol. 1989 Mar;50(3):399-401. doi: 10.1016/0090-1229(89)90147-5.
6
Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis.类风湿性关节炎患者滑液中类风湿因子与白细胞介素-6活性的相关性
Clin Exp Rheumatol. 1991 Jul-Aug;9(4):363-8.
7
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.克罗恩病中白细胞介素-6持续产生的证据。
Gastroenterology. 1992 Feb;102(2):514-9. doi: 10.1016/0016-5085(92)90098-j.